Department of Rheumatology.
Department of Clinical Chemistry and Laboratory Medicine.
Rheumatology (Oxford). 2017 Jul 1;56(7):1081-1088. doi: 10.1093/rheumatology/kew402.
To evaluate the prevalence of anti-extractable nuclear antigen (anti-ENA) antibodies in Dutch SSc patients and the predictive power of the combination of specific anti-ENA antibodies and nailfold videocapillaroscopy (NVC) patterns to improve identification of patients with high risk for cardiopulmonary involvement.
A total of 287 patients (79%) from the Leiden SSc-Cohort had data available on NVC-pattern (no SSc-specific, early, active, late) and anti-ENA antibodies. Associations between anti-ENA/NVC combinations with cardiopulmonary parameters were explored using logistic regression.
Prevalence of ACA was 37%, anti-Scl-70 24%, anti-RNP 9%, anti-RNAPIII 5%, anti-fibrillarin 4%, anti-Pm/Scl 3%, anti-Th/To 0.3% and anti-Ku 1.4%. NVC showed a SSc-specific pattern in 88%: 10% early, 42% active and 36% late. The prevalence of different NVC patterns was equally distributed among specific anti-ENA antibodies, except for the absence of early pattern in anti-RNP positive patients. Fifty-one percent had interstitial lung disease (ILD), 59% had decreased diffusion capacity for carbon monoxide and 16% systolic pulmonary artery pressure >35 mmHg (sPAP↑). Regardless of ENA-subtype, NVC-pattern showed a stable association with presence of ILD or sPAP↑. For ILD, the odds ratios (ORs) were 1.3-1.4 ( P < 0.05 for analyses with anti-RNAPIII, anti-RNP). For diffusion capacity for carbon monoxide, the OR was 1.5 ( P < 0.05 for analyses with ACA, anti-Scl-70, anti-RNAPIII, anti-RNP). For sPAP↑, the ORs were 2.2-2.4 ( P < 0.05 for analyses with anti-RNAPIII, anti-RNP).
In Dutch SSc patients, all SSc-specific auto-antibodies were found, with ACA and anti-Scl-70 being the most prevalent. Strikingly, the association between NVC-pattern and heart/lung involvement was independent of specific anti-ENA antibodies, which might indicate microangiopathy is an important cause of organ involvement.
评估荷兰系统性硬化症(SSc)患者中抗可提取核抗原(抗-ENA)抗体的流行情况,以及特定抗-ENA 抗体与甲襞毛细血管镜(NVC)模式相结合对提高心血管受累高风险患者识别率的预测能力。
莱顿 SSc 队列中的 287 名患者(79%)有 NVC 模式(无 SSc 特异性、早期、活跃、晚期)和抗 ENA 抗体的数据。使用逻辑回归探讨抗 ENA/NVC 组合与心肺参数之间的关系。
ACA 的患病率为 37%,抗 Scl-70 为 24%,抗 RNP 为 9%,抗 RNApIII 为 5%,抗纤维蛋白原为 4%,抗 Pm/Scl 为 3%,抗 Th/To 为 0.3%,抗 Ku 为 1.4%。NVC 表现为 88%的 SSc 特异性模式:10%早期,42%活跃,36%晚期。不同 NVC 模式的患病率在特定抗 ENA 抗体中均匀分布,除了抗 RNP 阳性患者中没有早期模式。51%的患者有间质性肺病(ILD),59%的患者一氧化碳弥散能力下降,16%的患者收缩期肺动脉压(sPAP↑)>35mmHg。无论 ENA 亚型如何,NVC 模式均与 ILD 或 sPAP↑存在稳定的相关性。对于 ILD,比值比(ORs)为 1.3-1.4(抗 RNApIII、抗 RNP 分析中 P<0.05)。对于一氧化碳弥散能力,OR 为 1.5(ACA、抗 Scl-70、抗 RNApIII、抗 RNP 分析中 P<0.05)。对于 sPAP↑,ORs 为 2.2-2.4(抗 RNApIII、抗 RNP 分析中 P<0.05)。
在荷兰 SSc 患者中,发现了所有的 SSc 特异性自身抗体,其中 ACA 和抗 Scl-70 最为常见。值得注意的是,NVC 模式与心肺受累之间的关联独立于特定的抗 ENA 抗体,这可能表明微血管病变是器官受累的一个重要原因。